Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors

<div>Imaging of HER2 expression in SKOV-3 xenografts (maximum intensity projection) using [<sup>125</sup>I]I-DARPin 9_29 (a) and [<sup>99m</sup>Tc]Tc(CO)<sub>3</sub>-DARPin 9_29 (b). Small-animal SPECT/CT imaging was performed at 6 h after injection.</div>

Contrast Media & Molecular Imaging

fig7

Figure 7

Figure 7: Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors 

Figure 7 | Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors 